148 related articles for article (PubMed ID: 2662129)
21. Opsonization of Legionella pneumophila in human serum: key roles for specific antibodies and the classical complement pathway.
Verbrugh HA; Lee DA; Elliott GR; Keane WF; Hoidal JR; Peterson PK
Immunology; 1985 Apr; 54(4):643-53. PubMed ID: 3980045
[TBL] [Abstract][Full Text] [Related]
22. Impaired opsonization by serum from patients with chronic liver disease.
Wyke RJ; Rajkovic IA; Williams R
Clin Exp Immunol; 1983 Jan; 51(1):91-8. PubMed ID: 6339126
[TBL] [Abstract][Full Text] [Related]
23. Opsonic and protective activity of immunoglobulin, modified immunoglobulin, and serum against neonatal Escherichia coli K1 infection.
Bortolussi R; Fischer GW
Pediatr Res; 1986 Feb; 20(2):175-8. PubMed ID: 3511443
[TBL] [Abstract][Full Text] [Related]
24. Opsonic activity of cord blood sera against various species of microorganism.
Máródi L; Leijh PC; Braat A; Daha MR; van Furth R
Pediatr Res; 1985 May; 19(5):433-6. PubMed ID: 3889816
[TBL] [Abstract][Full Text] [Related]
25. Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes.
Peterson PK; Wilkinson BJ; Kim Y; Schmeling D; Quie PG
Infect Immun; 1978 Mar; 19(3):943-9. PubMed ID: 640738
[TBL] [Abstract][Full Text] [Related]
26. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
Horwitz MA; Silverstein SC
J Clin Invest; 1980 Jan; 65(1):82-94. PubMed ID: 6985617
[TBL] [Abstract][Full Text] [Related]
27. Deficiencies in opsonic defense to pneumococci in the human newborn despite adequate levels of complement and specific IgG antibodies.
Geelen SP; Fleer A; Bezemer AC; Gerards LJ; Rijkers GT; Verhoef J
Pediatr Res; 1990 May; 27(5):514-8. PubMed ID: 2345679
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic variability of X-protein expression by mastitis-causing Streptococcus agalactiae of serotype NT/X and opsonic activities of specific antibodies.
Rainard P; Sarradin P; Poutrel B
Microb Pathog; 1994 May; 16(5):359-72. PubMed ID: 7815919
[TBL] [Abstract][Full Text] [Related]
29. Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors.
Weis JJ; Law SK; Levine RP; Cleary PP
J Immunol; 1985 Jan; 134(1):500-5. PubMed ID: 3880574
[TBL] [Abstract][Full Text] [Related]
30. Antibacterial host defense: in vitro interaction of bacteria, serum factors, and leukocytes from precolostral dairy calves and their dams.
Renshaw HW; Eckblad WP; Thacker DL; Frank FW
Am J Vet Res; 1976 Nov; 37(11):1267-74. PubMed ID: 791028
[TBL] [Abstract][Full Text] [Related]
31. Hereditary deficiency of the fifth component of complement in man. II. Biological properties of C5-deficient human serum.
Rosenfeld SI; Baum J; Steigbigel RT; Leddy JP
J Clin Invest; 1976 Jun; 57(6):1635-43. PubMed ID: 777027
[TBL] [Abstract][Full Text] [Related]
32. The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin.
Kerr MA; Falconer JS; Bashey A; Beck JS
Clin Exp Immunol; 1983 Dec; 54(3):793-800. PubMed ID: 6652976
[TBL] [Abstract][Full Text] [Related]
33. Dichotomy between opsonization and serum complement activation by encapsulated staphylococci.
Peterson PK; Kim Y; Wilkinson BJ; Schmeling D; Michael AF; Quie PG
Infect Immun; 1978 Jun; 20(3):770-5. PubMed ID: 352958
[TBL] [Abstract][Full Text] [Related]
34. A role for C-reactive protein in the complement-mediated stimulation of human neutrophils by type 27 Streptococcus pneumoniae.
Edwards KM; Gewurz H; Lint TF; Mold C
J Immunol; 1982 Jun; 128(6):2493-6. PubMed ID: 7077077
[TBL] [Abstract][Full Text] [Related]
35. Phagocytosis as a surface phenomenon. II. Contact angles and phagocytosis of encapsulated bacteria before and after opsonization by specific antiserum and complement.
Van Oss CJ; Gillman CF
J Reticuloendothel Soc; 1972 Nov; 12(5):497-502. PubMed ID: 4120360
[No Abstract] [Full Text] [Related]
36. Variability in the degree of opsonization and phagocytosis of strains of Staphylococcus aureus isolated from patients with disseminated intravascular coagulation.
Tuazon CU; Sheagren JN; Quie PG
J Lab Clin Med; 1981 Dec; 98(6):949-55. PubMed ID: 7310231
[TBL] [Abstract][Full Text] [Related]
37. Factor affecting the in vitro assessment of opsonization: a study of the kinetics of opsonization using the technique of phagocytic chemiluminescence.
Williams AJ; Hastings MJ; Easmon CS; Cole PJ
Immunology; 1980 Dec; 41(4):903-11. PubMed ID: 7007217
[TBL] [Abstract][Full Text] [Related]
38. Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin.
Gemmell CG; Peterson PK; Schmeling D; Kim Y; Mathews J; Wannamaker L; Quie PG
J Clin Invest; 1981 May; 67(5):1249-56. PubMed ID: 7014632
[TBL] [Abstract][Full Text] [Related]
39. Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A Streptococci. II. Human plasma cofactor (s) enhancing opsonization of encapsulated organisms.
STOLLERMAN GH; RYTEL M; ORTIZ J
J Exp Med; 1963 Jan; 117(1):1-17. PubMed ID: 13984363
[TBL] [Abstract][Full Text] [Related]
40. Antibodies raised against rough mutants of Escherichia coli and Salmonella strains are opsonic only in the presence of complement.
Vreede RW; Marcelis JH; Verhoef J
Infect Immun; 1986 Jun; 52(3):892-6. PubMed ID: 3519464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
